Institute of Microbial Chemistry (BIKAKEN), Tokyo, Japan.
J Antibiot (Tokyo). 2014 Apr;67(4):319-22. doi: 10.1038/ja.2013.143. Epub 2014 Jan 22.
A new trehalose analog, lentztrehalose [4-O-(2,3-dihydroxy-3-methylbutyl)trehalose], was isolated from an actinomycete Lentzea sp. Lentztrehalose is only weakly hydrolyzed by the trehalose-hydrolyzing enzyme, trehalase, so can be regarded as an enzyme-stable analog of trehalose. Although lentztrehalose does not show apparent toxicity to mammalian cells and microbes, it has antitumor activity in mice bearing S-180 sarcoma and Ehrlich carcinoma cells. In ovariectomized mice, lentztrehalose displayed a bone reinforcement effect in the femur that was superior to trehalose and induced non-morbid suppression of weight gain comparable with trehalose. These results indicate that enzyme-stable analogs of trehalose, such as lentztrehalose, may be more beneficial for human health and thus have potential as substitutes for trehalose as a sweetener.
一种新的海藻糖类似物,lentztrehalose [4-O-(2,3-二羟基-3-甲基丁基)海藻糖],从放线菌 Lentzea sp. 中分离得到。Lentztrehalose 仅被海藻糖水解酶,海藻糖酶,弱水解,因此可以被认为是海藻糖的酶稳定类似物。尽管 lentztrehalose 对哺乳动物细胞和微生物没有明显的毒性,但它在携带 S-180 肉瘤和 Ehrlich 癌细胞的小鼠中具有抗肿瘤活性。在去卵巢小鼠中,lentztrehalose 在股骨中表现出优于海藻糖的骨增强作用,并诱导与海藻糖相当的非病态体重增加抑制。这些结果表明,海藻糖的酶稳定类似物,如 lentztrehalose,可能对人类健康更有益,因此有可能替代海藻糖作为甜味剂。